Cargando…
Reducing inhibition: A promising new strategy for the treatment of schizophrenia
Autores principales: | Page, Chloe E., Coutellier, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161475/ https://www.ncbi.nlm.nih.gov/pubmed/30131309 http://dx.doi.org/10.1016/j.ebiom.2018.07.043 |
Ejemplares similares
-
Prefrontal parvalbumin cells are sensitive to stress and mediate anxiety-related behaviors in female mice
por: Page, Chloe E., et al.
Publicado: (2019) -
Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020) -
Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment
por: Zhang, Zichen, et al.
Publicado: (2022) -
Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia
por: Shepard, Ryan, et al.
Publicado: (2019) -
A New Treatment Strategy for Diabetic Dyslipidemia?
por: Kothari, Vishal, et al.
Publicado: (2020)